510(k) K844999
K844999 is an FDA 510(k) premarket notification submitted by Pharmacia, Inc. for the device "PHADEBACT CSF TEST". The FDA issued a decision of Substantially Equivalent on October 17, 1985. The device falls under product code GTJ (Antisera, All Groups, N. Meningitidis), a Class II device regulated under 21 CFR 866.3390. Pharmacia, Inc. has at least 10 other 510(k) clearances on record.
Clearance Details
- Decision
- SESE (Substantially Equivalent)
- Decision Date
- October 17, 1985
- Date Received
- December 26, 1984
- Clearance Type
- Traditional
- Expedited Review
- No
- Third Party Review
- No
Device Classification
- Device Name
- Antisera, All Groups, N. Meningitidis
- Device Class
- Class II
- Regulation Number
- 866.3390
- Review Panel
- MI
- Submission Type